Brief Summary

This clinical trial evaluates the feasibility of a novel tobacco cessation resource called a Buckeye Quit Stick among smokers with a diagnosed or suspected thoracic cancer. Tobacco use is the single most preventable cause of disease, disability, and death in the United States. While the benefits of quitting smoking are numerous, rates of persistent smoking after cancer diagnosis remain high. Research has found that patients who quit smoking but subsequently relapse frequently report the hand/oral habit as a barrier to sustained smoking cessation. The Buckeye Quit Stick is an innovative cessation aid designed to directly address patients' hand/oral habit by substituting the cessation aid for cigarettes without integrating pharmacologic intervention, which is typically managed by their medical provider and may require direct supervision due to the patient's health status. The Buckeye Quit Stick is designed to satisfy the repeated hand/oral pattern or ritual, thereby avoiding the physical loss of holding a cigarette in the hand or mouth and the action of smoking. It may also help occupy fidgeting hands and potentially reduce stress and cravings. This novel cessation resource may address key factors that influence smoking abstinence and improve patients' health outcomes.

Trial Health

Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment

participants targeted

Target at below P25 for not_applicable

Timeline

6mo left

Started May 2026

Shorter than P25 for not_applicable

Geographic Reach

1 country

1 active site

Status

not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

8 months study duration

Study Progress19%

May 2026Dec 2026

First Submitted

Initial submission to the registry

February 24, 2026

Completed

10 days until next milestone

First Posted

Study publicly available on registry

March 6, 2026

Completed

2 months until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed

8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

March 6, 2026

Status Verified

March 1, 2026

Enrollment Period

8 months

First QC Date

February 24, 2026

Last Update Submit

March 2, 2026

Conditions

Malignant Thoracic Neoplasm Cigarette Smoking-Related Carcinoma

Outcome Measures

Primary Outcomes (3)

Recruitment rates (feasibility)
To evaluate feasibility, recruitment rates will be defined as the proportion of screened adults accrued relative to those approached in the Ohio State University Comprehensive Cancer Center thoracic oncology clinic.
Up to 1 year
Adherence (feasibility)
Adherence will be assessed by evaluating the proportion of retained participants at each timepoint who complete required study procedures and assessments at each timepoint
at baseline, 2 weeks, 3 months and 6 months
Retention rates (feasibility)
Retention rates will be defined as the percentage of participants not lost to follow-up at 2-weeks, 3-months and 6-months post-enrollment. Descriptive statistics will be performed.
At 2 weeks, 3 months, and 6 months

Study Arms (1)

Prevention (Buckeye Quit Stick)

EXPERIMENTAL

Patients receive a Buckeye Quit Stick and a smoking cessation informational packet on study. Patients also receive a referral to the James CCC smoking cessation clinic on study.

Other: Electronic Health Record ReviewOther: Informational InterventionOther: InterviewOther: ReferralDevice: Smoking Cessation InterventionOther: Survey Administration